Back

Left ventricular mass including papillary muscles and trabeculations has greater prognostic value compared with maximum left ventricular wall thickness in hypertrophic cardiomyopathy

10 May 2026 (11:30 - 12:15)
Organised by: Logo
Congress Presentation Part of: Phenotyping, prognosis, and therapeutic strategies in infiltrative and hypertrophic cardiomyopathies Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Hyun-Jung Lee

Seoul National University Boramae Medical Center, Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Prediction of genotype positivity in patients with Hypertrophic Cardiomyopathy: validation of the Mayo score in a large Portuguese HCM cohort
Doctor S. Azevedo (Lisbon, PT)
Abstract Slides
Presentation thumbnail
The impact of sodium glucose cotransporter 2 inhibitors in hypertrophic cardiomyopathy: systematic review and meta-analysis
Associate Professor T. Chendey (Uzhgorod, UA)
Abstract Slides
Presentation thumbnail
Prevalence of transthyretin amyloid cardiomyopathy in at-risk outpatients: real-world data from a german multicentre ambulatory registry (BNK ATTRact Registry)
Doctor S. Schwarting (Munich, DE)
Abstract Slides
Presentation thumbnail
Conventional heart failure medication in immunoglobulin light-chain cardiac amyloidosis
Doctor C. Nitsche (Vienna, AT)
Abstract Slides
Presentation thumbnail
Relative efficacy of acoramidis, tafamidis and vutrisiran in patients with transthyretin amyloid cardiomyopathy: a multilevel network meta-regression
Doctor A. Jobbe Duval (Lyon, FR)
Abstract Slides

Access the full session

Session thumbnail
Phenotyping, prognosis, and therapeutic strategies in infiltrative and hypertrophic cardiomyopathies

The Event

Event poster

Heart Failure 2026

10 May 2026 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Adverse prognostic value of supernormal left ventricular force noninvasively assessed by resting transthoracic echocardiography in hypertrophic cardiomyopathy
10 December 2021
thumbnail
Congress Presentation
Scar architecture determinants of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study
16 April 2023
thumbnail
Congress Presentation
3 September 2019
thumbnail
Congress Presentation
Comparison between echocardiography and cardiac magnetic resonance for differential diagnosis of left ventricular hypertrophy
31 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources